Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Affymax/Takeda files new drug application (NDA) for peginesatide to treat anemia. |
 |
 |
| Pharma Business Review: Affymax and Takeda Pharmaceutical have filed a new drug application (NDA) for experimental drug peginesatide (formerly known as Hematide) as the treatment for anemia linked with chronic renal failure (CRF) in adult patients on dialysis, with the US Food and Drug Administration (FDA). |
